✦ LIBER ✦

Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study

✍ Scribed by Lees, A.; Ferreira, J.J.; Costa, R.; Rocha, J.-F.; Oliveira, C.; Lopes, N.; Nunes, T.; Soares-da-Silva, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind, Randomized, Placebo and

✍ Joaquim J. Ferreira; Olivier Rascol; Werner Poewe; Cristina Sampaio; José-Franci 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

An exploratory study of the efficacy and

✍ Hatano, Taku; Hattori, Nobutaka; Kawanabe, Tadaaki; Terayama, Yasuo; Suzuki, Nor 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 336 KB

Efficacy and tolerability of entacapone

✍ G. Fénelon; S. Giménez-Roldán; J. L. Montastruc; F. Bermejo; F. Durif; I. Bourde 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 121 KB

Levodopa/DDCI and entacapone is the pref

✍ P. Damier; F. Viallet; M. Ziegler; I. Bourdeix; K. Rerat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

A six-month multicentre, double-blind, b

✍ E. R. Brunt; D. J. Brooks; A. D. Korczyn; J.-L. Montastruc; F. Stocchi; on behal 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 79 KB

Efficacy, safety, and tolerance of the n

✍ Pinter, M M; Pogarell, O; Oertel, W H 📂 Article 📅 1999 🏛 BMJ Publishing Group 🌐 English ⚖ 195 KB